Redox Proteomics in Selected Neurodegenerative Disorders: from Its Infancy to Future Applications Allan Butterfield University of Kentucky
Total Page:16
File Type:pdf, Size:1020Kb
Eastern Kentucky University Encompass Chemistry Faculty and Staff choS larship Chemistry 2012 Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications Allan Butterfield University of Kentucky Marzia Perluigi Sapienza University of Rome Tanea Reed Eastern Kentucky University Tasneem Muharib University of Kentucky Christopher P. Hughes University of Kentucky See next page for additional authors Follow this and additional works at: http://encompass.eku.edu/che_fsresearch Part of the Chemistry Commons Recommended Citation Butterfield, D. A., Perluigi, M., Reed, T., Muharib, T., Hughes, C. P., Robinson, R. A., & Sultana, R. (2012). Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications. Antioxidants & Redox Signaling, 17(11), 1610-1655. doi:10.1089/ars.2011.4109 This Article is brought to you for free and open access by the Chemistry at Encompass. It has been accepted for inclusion in Chemistry Faculty and Staff Scholarship by an authorized administrator of Encompass. For more information, please contact [email protected]. Authors Allan Butterfield, Marzia Perluigi, Tanea Reed, Tasneem Muharib, Christopher P. Hughes, Rena A.S. Robinson, and Rukhsana Sultana This article is available at Encompass: http://encompass.eku.edu/che_fsresearch/3 See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/51828850 Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications Article in Antioxidants & Redox Signaling · November 2011 Impact Factor: 7.41 · DOI: 10.1089/ars.2011.4109 · Source: PubMed CITATIONS READS 72 32 7 authors, including: D. Allan Butterfield Marzia Perluigi University of Kentucky Sapienza University of Rome 628 PUBLICATIONS 39,353 CITATIONS 113 PUBLICATIONS 3,459 CITATIONS SEE PROFILE SEE PROFILE Tanea Reed Renã A S Robinson Eastern Kentucky University University of Pittsburgh 17 PUBLICATIONS 1,404 CITATIONS 30 PUBLICATIONS 355 CITATIONS SEE PROFILE SEE PROFILE All in-text references underlined in blue are linked to publications on ResearchGate, Available from: Tanea Reed letting you access and read them immediately. Retrieved on: 11 May 2016 ANTIOXIDANTS & REDOX SIGNALING Volume 17, Number 11, 2012 COMPREHENSIVE INVITED REVIEW ª Mary Ann Liebert, Inc. DOI: 10.1089/ars.2011.4109 Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications D. Allan Butterfield,1 Marzia Perluigi,2 Tanea Reed,3 Tasneem Muharib,4 Christopher P. Hughes,4 Rena˜ A.S. Robinson,4 and Rukhsana Sultana1 Abstract Several studies demonstrated that oxidative damage is a characteristic feature of many neurodegenerative diseases. The accumulation of oxidatively modified proteins may disrupt cellular functions by affecting protein expression, protein turnover, cell signaling, and induction of apoptosis and necrosis, suggesting that protein oxidation could have both physiological and pathological significance. For nearly two decades, our laboratory focused particular attention on studying oxidative damage of proteins and how their chemical modifications induced by reactive oxygen species/reactive nitrogen species correlate with pathology, biochemical alterations, and clinical presentations of Alzheimer’s disease. This comprehensive article outlines basic knowledge of oxi- dative modification of proteins and lipids, followed by the principles of redox proteomics analysis, which also involve recent advances of mass spectrometry technology, and its application to selected age-related neurode- generative diseases. Redox proteomics results obtained in different diseases and animal models thereof may provide new insights into the main mechanisms involved in the pathogenesis and progression of oxidative- stress-related neurodegenerative disorders. Redox proteomics can be considered a multifaceted approach that has the potential to provide insights into the molecular mechanisms of a disease, to find disease markers, as well as to identify potential targets for drug therapy. Considering the importance of a better understanding of the cause/effect of protein dysfunction in the pathogenesis and progression of neurodegenerative disorders, this article provides an overview of the intrinsic power of the redox proteomics approach together with the most significant results obtained by our laboratory and others during almost 10 years of research on neurodegener- ative disorders since we initiated the field of redox proteomics. Antioxid. Redox Signal. 17, 1610–1655. I. Introduction 1611 II. Protein (/Lipid) Oxidation and Protein Dysfunction 1611 A. Protein carbonyls 1612 B. Protein nitration 1613 1. Peroxynitrite (ONOO - ) 1615 2. Nitrogen dioxide (NO2) 1616 C. HNE adduction to proteins 1616 D. Importance of clearance and detoxification systems 1616 1. The proteasome, parkin, ubiquitin carboxy-terminal hydrolase-L1, and HSPs 1616 2. Superoxide dismutase 1617 3. Catalase 1618 4. Peroxiredoxins 1618 5. Trx and Trx reductase 1618 6. Glutathione reductase 1618 7. Vitamins in neurodegeneration 1618 8. Involvement of iron in neurodegeneration 1618 Reviewing Editors: Michalis Aivaliotis, Valentino Bonetto, Howard Gendelman, Pietro Ghezzi, Mahin Maines, Jan Ottervald, Junji Yodoi, and Moussa Youdim 1Department of Chemistry, Center of Membrane Sciences, Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky. 2Department of Biochemical Sciences, Sapienza University of Rome, Rome, Italy. 3Department of Chemistry, Eastern Kentucky University of Kentucky, Richmond, Kentucky. 4Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania. 1610 REDOX PROTEOMICS IN NEURODEGENERATIVE DISORDERS 1611 E. Role of iron in neurodegeneration 1620 1. Fe homeostasis in AD 1620 2. Fe homeostasis in PD 1620 3. Fe homeostasis in ALS 1620 4. Fe homeostasis in HD 1620 F. Some known consequences of protein oxidation 1621 III. Overview of Redox Proteomics 1621 A. Global, gel-based approaches 1621 B. Targeted, gel-free approach 1623 1. Enrichment of PCO modified proteins 1623 2. Enrichment of HNE modified proteins 1624 3. Enrichment of 3-NT modified proteins 1624 IV. Application of Redox Proteomics to Selected Neurodegenerative Disorders 1626 A. Alzheimer’s disease 1626 1. PCO in AD 1626 2. Identification of carbonylated proteins in brain of subjects with AD 1627 a. Sample: the brain 1627 b. Energy dysfunction 1627 c. Excitotoxicity 1628 d. Proteosomal dysfunction 1628 e. Neuritic abnormalities 1628 f. APP regulation, tau hyperphosphorylation, and cell cycle regulation 1628 g. Synaptic abnormalities and LTP 1629 h. pH maintenance 1629 i. Mitochondrial abnormalities 1629 3. Carbonylated proteins in brain of subjects with amnestic MCI 1629 4. EAD carbonylated proteins 1630 5. PCAD vs. amnestic MCI protein carbonylation in brain 1630 6. Protein-bound HNE in brain and progression of Alzheimer’s disease 1630 7. Protein-bound 3-NT in brain and progression of Alzheimer’s disease 1632 8. Nitrated brain proteins in MCI 1632 9. Nitrated proteins in EAD 1633 B. Parkinson disease 1633 1. Redox proteomics in PD 1635 C. Amyotrophic lateral sclerosis 1635 1. Redox proteomics studies in ALS transgenic mice 1636 D. Huntington disease 1637 1. Redox proteomics-transgenic mouse model of HD 1638 2. Proteomics of HD brain 1638 E. Down syndrome 1638 1. Redox proteomics in DS transgenic mice 1639 V. Conclusions and Future Directions 1639 I. Introduction neurodegenerative disorders (63, 180). Free radicals are generated in vivo from various sources, one of the major edox proteomics is the subset of proteomics in which sources being the leakage of superoxide radical from the Roxidatively or nitrosatively modified proteins are iden- mitochondria (Fig. 1). Under physiological conditions, levels .2 tified (115). Our laboratory was among the first that used of superoxide anion radicals (O2 ) are maintained in the cell redox proteomics to identify oxidatively modified brain pro- by the antioxidant enzyme, superoxide dismutase (SOD), .2 teins (91, 92, 233). Others first used redox proteomics to identify which disproportionates O2 to hydrogen peroxide (H2O2) oxidized thiols (34, 88, 157, 250). Redox proteomics has been and oxygen (Fig. 1). Further, the H2O2 formed is converted applied to numerous disorders known to be associated with to water and oxygen by the enzymes catalase, peroxidase, or oxidative stress (OS) (115). This comprehensive article focuses glutathione peroxidase (GPx). GPx uses reduced glutathione on applications and results of redox proteomics that provide (GSH) to carry out its functions, and the levels of reduced insights into selected neurodegenerative disorders. GSH are maintained by the enzyme glutathione reductase (GR), which converts oxidized glutathione (GSSG) to GSH using NADPH for reducing equivalents. In the brain, the II. Protein (/Lipid) Oxidation and Protein Dysfunction levels of catalase are greater than those for GPx. The OS induced by free radicals plays an important role in the importance of these enzymes in relation to neurodegenera- pathophysiology of a wide variety of diseases including tion will be discussed in further detail next. During 1612 BUTTERFIELD ET AL. FIG. 1. Free radicals are generated by various mechanisms. One way by which free radicals are generated is via release of superoxide anion from the mitochondria, leading to increased formation of reactive oxygen and reactive nitrogen species and, consequently, damaging the biomolecules. (To see this illustration